Latest Capital Raising News

Zimi Limited reported a remarkable 367% increase in quarterly revenue alongside a successful $1.85 million capital raise and completion of its manufacturing relocation, setting the stage for accelerated growth in the smart home IoT sector.

CuFe Ltd has announced a dramatic 400% increase in contained copper at its Gecko project, alongside an upgraded Orlando resource and a $5.4 million capital raise to advance its Tennant Creek development plans.

Star Minerals has raised $1.5 million through a share placement to fund critical drilling and mining approvals at its Tumblegum South Gold Project, aiming for production start in early 2026.

Ionic Rare Earths advances its global rare earths strategy with significant UK government funding, increased heavy rare earth oxide production, and a $15.6 million capital raise backed by a strategic US investor.

Locate Technologies reports a 19% revenue increase in its Locate2u segment and progresses toward a December 2025 NZX listing, supported by new board appointments and a NZD 10 million ATM facility.

Ballard Mining has raised $20.6 million through a premium share placement led by new strategic investor Aurenne Group Holdings, aiming to accelerate exploration and resource growth at its Mt Ida Gold Project. A new, substantial October 2025 Exploration Target highlights significant upside beyond the existing mineral resources.

Power Minerals Limited has advanced its critical minerals portfolio with the acquisition of the Gamma Heavy Rare Earths and Uranium Project in California and completed the Santa Anna Niobium-REE-Gallium Project acquisition in Brazil, supported by a combined $6.7 million capital raise.

Pursuit Minerals progresses its Rio Grande Sur lithium project with a refined commercial plan and feasibility study, while expanding into gold through the Sascha Marcelina acquisition. A recent $4 million placement strengthens its financial position for growth.

Odyssey Gold Limited has reported significant progress on its Tuckanarra Gold Project, including a positive Mining Technical Study, robust drilling results, and a $4 million capital raise to fund ongoing exploration and development.

Amplia Therapeutics reports encouraging interim results for narmafotinib in metastatic pancreatic cancer, alongside a successful capital raise and key patent allowance.

Rhythm Biosciences reports strong Q1 FY26 progress, securing strategic partnerships and advancing commercial readiness for its ColoSTAT® colorectal cancer test alongside robust growth in its geneType platform.

Adslot Ltd reports solid progress in Q1 FY26, highlighting growth in its StoreFront and Marketplace platforms alongside a successful $989,000 capital raise to fuel expansion.